世界のアルテミシニンAPI市場インサイト・予測(~2027)

QYResearchが発行した調査報告書(QY21AUG0645)
◆英語タイトル:Global Artemisinin API Market Insights and Forecast to 2027
◆商品コード:QY21AUG0645
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年8月(※2024年版があります。お問い合わせください。)
◆ページ数:113
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはアルテミシニンAPIの世界市場の現状について調査・分析し、2027年までの市場を予測しました。アルテミシニンAPIの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(クソニンジン抽出、半合成アルテミシニン)、用途別市場規模(抗マラリア注射、抗マラリア錠)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・アルテミシニンAPIの世界市場概要
・メーカー別の競争状況、市場シェア
・アルテミシニンAPIの種類別市場規模:クソニンジン抽出、半合成アルテミシニン
・アルテミシニンAPIの用途別市場規模:抗マラリア注射、抗マラリア錠
・北米のアルテミシニンAPI市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパのアルテミシニンAPI市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアのアルテミシニンAPI市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米のアルテミシニンAPI市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカのアルテミシニンAPI市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Sanofi、KPC Pharmaceuticals、Kerui nanhai、Guangxi xiancaotang、Guilin Pharmaceutical、Natural Bio-engineering、BIONEXX、CAT KHANH、BEEPZ、Novanat Bioresource
・アルテミシニンAPIのバリューチェーン・販売チャネル分析
・アルテミシニンAPIの世界市場動向
【レポートの概要】

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Market Analysis and Insights: Global Artemisinin API Market
The global Artemisinin API market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Artemisinin API Scope and Segment
Artemisinin API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artemisinin API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Extraction from Artemisia annua
Semisynthetic Artemisinin

Segment by Application
Antimalarial Injections
Antimalarial Tablets

By Company
Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Guilin Pharmaceutical
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Novanat Bioresource

Production by Region
North America
Europe
China
Japan

Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

【レポートの目次】

1 Study Coverage
1.1 Artemisinin API Product Introduction
1.2 Market by Type
1.2.1 Global Artemisinin API Market Size Growth Rate by Type
1.2.2 Extraction from Artemisia annua
1.2.3 Semisynthetic Artemisinin
1.3 Market by Application
1.3.1 Global Artemisinin API Market Size Growth Rate by Application
1.3.2 Antimalarial Injections
1.3.3 Antimalarial Tablets
1.4 Study Objectives
1.5 Years Considered

2 Global Artemisinin API Production
2.1 Global Artemisinin API Production Capacity (2016-2027)
2.2 Global Artemisinin API Production by Region: 2016 VS 2021 VS 2027
2.3 Global Artemisinin API Production by Region
2.3.1 Global Artemisinin API Historic Production by Region (2016-2021)
2.3.2 Global Artemisinin API Forecasted Production by Region (2022-2027)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan

3 Global Artemisinin API Sales in Volume & Value Estimates and Forecasts
3.1 Global Artemisinin API Sales Estimates and Forecasts 2016-2027
3.2 Global Artemisinin API Revenue Estimates and Forecasts 2016-2027
3.3 Global Artemisinin API Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Artemisinin API Regions by Sales
3.4.1 Global Top Artemisinin API Regions by Sales (2016-2021)
3.4.2 Global Top Artemisinin API Regions by Sales (2022-2027)
3.5 Global Top Artemisinin API Regions by Revenue
3.5.1 Global Top Artemisinin API Regions by Revenue (2016-2021)
3.5.2 Global Top Artemisinin API Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa

4 Competition by Manufactures
4.1 Global Artemisinin API Production Capacity by Manufacturers
4.2 Global Artemisinin API Sales by Manufacturers
4.2.1 Global Top Artemisinin API Manufacturers by Sales (2016-2021)
4.2.2 Global Top Artemisinin API Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Artemisinin API Sales in 2020
4.3 Global Artemisinin API Revenue by Manufacturers
4.3.1 Global Top Artemisinin API Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Artemisinin API Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Artemisinin API Revenue in 2020
4.4 Global Artemisinin API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Artemisinin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Artemisinin API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type
5.1 Global Artemisinin API Sales by Type
5.1.1 Global Artemisinin API Historical Sales by Type (2016-2021)
5.1.2 Global Artemisinin API Forecasted Sales by Type (2022-2027)
5.1.3 Global Artemisinin API Sales Market Share by Type (2016-2027)
5.2 Global Artemisinin API Revenue by Type
5.2.1 Global Artemisinin API Historical Revenue by Type (2016-2021)
5.2.2 Global Artemisinin API Forecasted Revenue by Type (2022-2027)
5.2.3 Global Artemisinin API Revenue Market Share by Type (2016-2027)
5.3 Global Artemisinin API Price by Type
5.3.1 Global Artemisinin API Price by Type (2016-2021)
5.3.2 Global Artemisinin API Price Forecast by Type (2022-2027)

6 Market Size by Application
6.1 Global Artemisinin API Sales by Application
6.1.1 Global Artemisinin API Historical Sales by Application (2016-2021)
6.1.2 Global Artemisinin API Forecasted Sales by Application (2022-2027)
6.1.3 Global Artemisinin API Sales Market Share by Application (2016-2027)
6.2 Global Artemisinin API Revenue by Application
6.2.1 Global Artemisinin API Historical Revenue by Application (2016-2021)
6.2.2 Global Artemisinin API Forecasted Revenue by Application (2022-2027)
6.2.3 Global Artemisinin API Revenue Market Share by Application (2016-2027)
6.3 Global Artemisinin API Price by Application
6.3.1 Global Artemisinin API Price by Application (2016-2021)
6.3.2 Global Artemisinin API Price Forecast by Application (2022-2027)

7 North America
7.1 North America Artemisinin API Market Size by Type
7.1.1 North America Artemisinin API Sales by Type (2016-2027)
7.1.2 North America Artemisinin API Revenue by Type (2016-2027)
7.2 North America Artemisinin API Market Size by Application
7.2.1 North America Artemisinin API Sales by Application (2016-2027)
7.2.2 North America Artemisinin API Revenue by Application (2016-2027)
7.3 North America Artemisinin API Sales by Country
7.3.1 North America Artemisinin API Sales by Country (2016-2027)
7.3.2 North America Artemisinin API Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada

8 Europe
8.1 Europe Artemisinin API Market Size by Type
8.1.1 Europe Artemisinin API Sales by Type (2016-2027)
8.1.2 Europe Artemisinin API Revenue by Type (2016-2027)
8.2 Europe Artemisinin API Market Size by Application
8.2.1 Europe Artemisinin API Sales by Application (2016-2027)
8.2.2 Europe Artemisinin API Revenue by Application (2016-2027)
8.3 Europe Artemisinin API Sales by Country
8.3.1 Europe Artemisinin API Sales by Country (2016-2027)
8.3.2 Europe Artemisinin API Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia

9 Asia Pacific
9.1 Asia Pacific Artemisinin API Market Size by Type
9.1.1 Asia Pacific Artemisinin API Sales by Type (2016-2027)
9.1.2 Asia Pacific Artemisinin API Revenue by Type (2016-2027)
9.2 Asia Pacific Artemisinin API Market Size by Application
9.2.1 Asia Pacific Artemisinin API Sales by Application (2016-2027)
9.2.2 Asia Pacific Artemisinin API Revenue by Application (2016-2027)
9.3 Asia Pacific Artemisinin API Sales by Region
9.3.1 Asia Pacific Artemisinin API Sales by Region (2016-2027)
9.3.2 Asia Pacific Artemisinin API Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia

10 Latin America
10.1 Latin America Artemisinin API Market Size by Type
10.1.1 Latin America Artemisinin API Sales by Type (2016-2027)
10.1.2 Latin America Artemisinin API Revenue by Type (2016-2027)
10.2 Latin America Artemisinin API Market Size by Application
10.2.1 Latin America Artemisinin API Sales by Application (2016-2027)
10.2.2 Latin America Artemisinin API Revenue by Application (2016-2027)
10.3 Latin America Artemisinin API Sales by Country
10.3.1 Latin America Artemisinin API Sales by Country (2016-2027)
10.3.2 Latin America Artemisinin API Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Artemisinin API Market Size by Type
11.1.1 Middle East and Africa Artemisinin API Sales by Type (2016-2027)
11.1.2 Middle East and Africa Artemisinin API Revenue by Type (2016-2027)
11.2 Middle East and Africa Artemisinin API Market Size by Application
11.2.1 Middle East and Africa Artemisinin API Sales by Application (2016-2027)
11.2.2 Middle East and Africa Artemisinin API Revenue by Application (2016-2027)
11.3 Middle East and Africa Artemisinin API Sales by Country
11.3.1 Middle East and Africa Artemisinin API Sales by Country (2016-2027)
11.3.2 Middle East and Africa Artemisinin API Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE

12 Corporate Profiles
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Overview
12.1.3 Sanofi Artemisinin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Artemisinin API Product Description
12.1.5 Sanofi Recent Developments
12.2 KPC Pharmaceuticals
12.2.1 KPC Pharmaceuticals Corporation Information
12.2.2 KPC Pharmaceuticals Overview
12.2.3 KPC Pharmaceuticals Artemisinin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 KPC Pharmaceuticals Artemisinin API Product Description
12.2.5 KPC Pharmaceuticals Recent Developments
12.3 Kerui nanhai
12.3.1 Kerui nanhai Corporation Information
12.3.2 Kerui nanhai Overview
12.3.3 Kerui nanhai Artemisinin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Kerui nanhai Artemisinin API Product Description
12.3.5 Kerui nanhai Recent Developments
12.4 Guangxi xiancaotang
12.4.1 Guangxi xiancaotang Corporation Information
12.4.2 Guangxi xiancaotang Overview
12.4.3 Guangxi xiancaotang Artemisinin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 Guangxi xiancaotang Artemisinin API Product Description
12.4.5 Guangxi xiancaotang Recent Developments
12.5 Guilin Pharmaceutical
12.5.1 Guilin Pharmaceutical Corporation Information
12.5.2 Guilin Pharmaceutical Overview
12.5.3 Guilin Pharmaceutical Artemisinin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.5.4 Guilin Pharmaceutical Artemisinin API Product Description
12.5.5 Guilin Pharmaceutical Recent Developments
12.6 Natural Bio-engineering
12.6.1 Natural Bio-engineering Corporation Information
12.6.2 Natural Bio-engineering Overview
12.6.3 Natural Bio-engineering Artemisinin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.6.4 Natural Bio-engineering Artemisinin API Product Description
12.6.5 Natural Bio-engineering Recent Developments
12.7 BIONEXX
12.7.1 BIONEXX Corporation Information
12.7.2 BIONEXX Overview
12.7.3 BIONEXX Artemisinin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.7.4 BIONEXX Artemisinin API Product Description
12.7.5 BIONEXX Recent Developments
12.8 CAT KHANH
12.8.1 CAT KHANH Corporation Information
12.8.2 CAT KHANH Overview
12.8.3 CAT KHANH Artemisinin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.8.4 CAT KHANH Artemisinin API Product Description
12.8.5 CAT KHANH Recent Developments
12.9 BEEPZ
12.9.1 BEEPZ Corporation Information
12.9.2 BEEPZ Overview
12.9.3 BEEPZ Artemisinin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.9.4 BEEPZ Artemisinin API Product Description
12.9.5 BEEPZ Recent Developments
12.10 Novanat Bioresource
12.10.1 Novanat Bioresource Corporation Information
12.10.2 Novanat Bioresource Overview
12.10.3 Novanat Bioresource Artemisinin API Sales, Price, Revenue and Gross Margin (2016-2021)
12.10.4 Novanat Bioresource Artemisinin API Product Description
12.10.5 Novanat Bioresource Recent Developments

13 Industry Chain and Sales Channels Analysis
13.1 Artemisinin API Industry Chain Analysis
13.2 Artemisinin API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Artemisinin API Production Mode & Process
13.4 Artemisinin API Sales and Marketing
13.4.1 Artemisinin API Sales Channels
13.4.2 Artemisinin API Distributors
13.5 Artemisinin API Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Artemisinin API Industry Trends
14.2 Artemisinin API Market Drivers
14.3 Artemisinin API Market Challenges
14.4 Artemisinin API Market Restraints

15 Key Finding in The Global Artemisinin API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Sanofi、KPC Pharmaceuticals、Kerui nanhai、Guangxi xiancaotang、Guilin Pharmaceutical、Natural Bio-engineering、BIONEXX、CAT KHANH、BEEPZ、Novanat Bioresource

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のアルテミシニンAPI市場インサイト・予測(~2027)(Global Artemisinin API Market Insights and Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。